Cite
HARVARD Citation
Weber, J. et al. (2015). Pre-treatment patient selection for nivolumab benefit based on serum mass spectra. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Weber, J. et al. (2015). Pre-treatment patient selection for nivolumab benefit based on serum mass spectra. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online].